Navigation Links
Market Access Trends Report Outlines Eleven Major Trends Impacting The U.S. Healthcare System
Date:7/15/2013

PARSIPPANY, N.J., July 15, 2013 /PRNewswire/ -- Pinsonault, in conjunction with HealthLeaders-InterStudy, recently published the Market Access Trends Report, a 48-page report highlighting key trends that are changing the U.S. healthcare system.

"We touch on eleven big trends in this report, including how Medicare Star ratings offer partnership opportunities for pharma, why it's important to know the players in narrow-network health plans and how pharma fits into new reimbursement models such as shared savings and bundled payments," said Sheri Sellmeyer, Vice President, Market Analysis at HealthLeaders-InterStudy and one of the report's authors.

Key findings include:

  • Healthcare and payment reform will change market access
  • Insurers will continue to offer narrow-network plans and high-deductible options as a way to hold down premiums as they field products in the state exchanges
  • Medicaid, because it's a growing segment of healthcare benefits, will make market access for certain drugs a challenge with stringent Rx management and tight formularies by states
  • With growth in specialty drugs, payers are using multiple strategies to make sure patients are using the best drugs, that they are compliant and that they have assumed an appropriate amount of out-of-pocket expense on such drugs

The complete Market Access Trends Report is available for purchase. For more information, please contact Christine MacAdams at cmacadams@pinsonault.com or by calling 215-280-4734.

About Pinsonault
Pinsonault, a division of Decision Resources Group, is dedicated to and focused on delivering high quality, Managed Markets specific, business and training solutions within the pharmaceutical and biotech industries. The organization strives to create customer specific solutions that provide valuable strategic insight and results oriented tactical tools enabling clients to identify and capitalize on Managed Markets business opportunities. For more information, visit Pinsonault.com.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. For more information, visit DecisionResourcesGroup.com.


'/>"/>
SOURCE Pinsonault
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. SynGen Inc. Receives FDA 510K Clearance to Market SynGenX-1000 Cord Blood Processing Platform
2. TPI Corporate Presentation Updated Regarding Macrolide API Market
3. Global Blood Pressure Monitor Market 2012-2016: High Competition among Vendors Could Pose a Challenge to Growth of this Market
4. Mature US and European coronary artery bypass graft device markets will Shrink through 2021
5. Global Medical Devices Survey 2013-2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry
6. Global Antiviral Therapeutics Report - Technologies, Markets and Companies - 2013-2022
7. Neurostimulation Devices Market, 2012 - 2017
8. Companion Diagnostics Market, 2012-2023
9. Alzheimers Drugs Market, 2012 - 2017
10. Prefilled Syringes Market, 2013 - 2023
11. South Asia Medical Device Market Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , March 27, 2017  Cryoport, Inc. (NASDAQ: CYRX, ... intends to offer shares of common stock in an ... on file with the Securities and Exchange Commission (the ... conditions, and there can be no assurance as to ... as to the actual size or terms of the ...
(Date:3/27/2017)... 2017 To mark the end of Save Your ... leader in digital imaging solutions, will showcase Canon eye care ... New York,s Jacob Javits Center from ... sponsored by the American Optometric Association, is observed annually in ... comprehensive eye exams. In recognition of this observance, Canon ...
(Date:3/27/2017)... March 27, 2017  Sophiris Bio Inc. (NASDAQ: ... a clinical late-stage biopharmaceutical company developing topsalysin (PRX302) ... today reported fourth quarter and full year 2016 ... Key Corporate Highlights: Advanced ... Cancer. During 2016, the Company reported successful results ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... March 27, 2017 , ... Osteitis pubis may be commonplace ... injury, it occurs when the muscles around the pelvis become inflamed. Over time, ... lower torso, as well as accompanying tenderness and weakness. Without proper intervention, it ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... epigenetic research products enables researchers to pursue the recent RNA methylation “gold rush” ... . In light of the newfound characteristics of N6-methyladenosine, or m6A , ...
(Date:3/27/2017)... ... March 27, 2017 , ... Janet Schloz is still in shock after receiving a $2,500 ... had in a long time,” she said. , She thinks the coming week is going ... never thought I would have to help my students.” , The award will allow the ...
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium ... methods are complicated and require expert user knowledge. In a live webinar on ... to the simplified, yet highly accurate, determination of sodium. , It has long ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... facility from 8:00am-10:00am on Monday, April 3rd to commemorate the two-year anniversary of ... opportunity for area-residents to celebrate two great years while also familiarizing themselves with ...
Breaking Medicine News(10 mins):